User contributions for CFRCitation
10 August 2023
- 21:4121:41, 10 August 2023 diff hist +2,228 User talk:CFRCitation →Sockpuppet claim: new section Tags: Mobile edit Mobile web edit New topic
- 19:3819:38, 10 August 2023 diff hist +976 User talk:CFRCitation No edit summary
4 August 2023
- 22:4922:49, 4 August 2023 diff hist +567 User talk:CFRCitation →August 2023: Reply Tags: Mobile edit Mobile web edit Reply
- 22:4722:47, 4 August 2023 diff hist +366 Talk:Simufilam →Knee-jerk reversing corrections to error and adding research in Pharmacology section: Reply Tags: Mobile edit Mobile web edit Reply
- 18:3818:38, 4 August 2023 diff hist +753 Simufilam See talk page. I. The statement "no other researchers have examined simufilam binding to FLNA" is not correct and is not supported by the citation. Subsequent research cited in this article contradicts this claim (though the burden of proof is on the one adding a claim). 2. The wording regarding the mouse study clarifies that the mice had overexpressed FLNA (which is relevant to much talk/debate). 3. This adds additional research of Simufilam modulation of aberrant FLNA activity. Tag: Visual edit: Switched
- 18:3818:38, 4 August 2023 diff hist +1,239 Talk:Simufilam →Knee-jerk reversing corrections to error and adding research in Pharmacology section: new section Tag: New topic
- 18:1518:15, 4 August 2023 diff hist +368 User talk:CFRCitation →August 2023: Reply Tag: Reply
- 17:2617:26, 4 August 2023 diff hist +758 Simufilam →Pharmacology: These edits were improperly reversed along with another's unrelated changes.These edits improved the page by correcting errors and adding relevant research. They were previously justified as per the below an such justification has been ignored: I. The statement "no other researchers have examined simufilam binding to FLNA" is not correct and is not supported by the citation. Subsequent research cited in this article contradicts this claim (though the burden of proof is on... Tags: Reverted Mobile edit Mobile web edit
2 August 2023
- 22:4922:49, 2 August 2023 diff hist +781 Simufilam I. The statement "no other researchers have examined simufilam binding to FLNA" is not correct and is not supported by the citation. Subsequent research cited in this article contradicts this claim (though the burden of proof is on the one adding a claim). 2. The wording regarding the mouse study clarifies that the mice had overexpressed FLNA (which is relevant to much talk/debate). 3. This adds additional research of Simufilam modulation of aberrant FLNA activity. Tags: Reverted Visual edit
15 January 2022
- 00:0900:09, 15 January 2022 diff hist +1,490 David S. Bredt This edit is reverting to the version set by Baahorn on December 28, 2021. Baahorn mentioned this page may need to be locked - that would be appropriate with his version (now current). An anonymous user has made multiple changes to remove content claiming it was "meant to smear" the reputation of David Bredt. The content is factual, sourced, and relevant to Bredt's co-authorship of a citizen's petition seeking to halt a phase 3 trial. Tag: Visual edit
 |
|